Company: HCTI
Filing Date: 2025-04-22
Form Type: S-1/A
Source: 0001213900-25-034248
Chunk: 19

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-22
Form: S-1/A
Chunk 19
---
 available for the resale of all
Registrable Securities, provided, however, if less than all Registrable Securities have become registered for resale on the date that
the Registration Statement is declared effective, such holder with respect to itself only, shall have the right in its sole and absolute
discretion to deem such condition satisfied, including with regard only to the Registrable Securities that have been so registered, (2)
such holder can sell all Registrable Securities pursuant to Rule 144 without restriction or limitation or (3) twelve (12) months immediately
following the issuance of the Purchase Warrants (any such date, an “Exercise Date”), solely with respect to such portion of
the Purchase Warrant being exercised on such applicable Exercise Date, (a) such applicable Exercise Date shall be deemed to mean the Adjustment
Date, (b) such applicable Adjustment Period shall be deemed to have commenced on the applicable date set forth in clause (1), (2) or (3)
hereof, as applicable and ended on the eleventh (11th) Trading Day thereafter and (c) the applicable Adjustment Price and Adjustment Share
Amount for such exercised Purchase Warrants shall be calculated as stated in the previous paragraph.

<div align='center'>8</div>

The Purchase Warrants also
contain anti-dilution protection (subject to the floor price of $0.084) against Dilutive Issuances (as defined in the Purchase Warrants),
whereby the exercise price and the number of shares of Common Stock underlying the Purchase Warrants is subject to reset in the same manner
as described above.

The exercise price (subject
to the floor price of $0.084) and number of shares of Common Stock underlying the Purchase Warrants will also reset if there occurs any
share split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the Company’s
Common Stock (each, a “Share Combination Event”) and the lowest Weighted Average Price of the Common Stock during the period
commencing on the trading day immediately following the applicable Share Combination Event and ending on the fifth (5th) trading day immediately
following the applicable Share Combination Event Date is less than the Exercise Price then in effect in the same manner described above.

In addition, a holder
of Series B Warrants may, at any time and in its sole discretion, exercise its Series B Warrants in whole or in part by means of a “zero
exercise price” option in which the holder is entitled to receive a number